Drug recall: Sodium Bicarbonate Injection recalled due to this reason

The product is used for the treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton.

285
Drug recall
Drug recall

Last Updated on October 10, 2024 by The Health Master

Drug recall:

Exela Pharma Sciences, LLC (Exela) is voluntarily recalling 49 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton, to the consumer level.

Risk Statement:

The product poses a potential safety concern with vial breakage and flying glass when pressurized while preparing the product for administration.

Exela has received five (5) reports of flying glass injuring the skin, eye, and/or other parts. There have been no reports of sterility failures.

The product is used for the treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton.

The vials are labeled with Exela brand (Carton NDC: 51754-5001-5; Vial NDC: 51754-5001-1, Figure 1) and Civica brand (Carton NDC: 72572-740-20; Vial NDC: 72572-740-1, Figure 2).

The affected Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL lots (covering both Exela and Civica brands) include the following lot numbers and expiration dates:

All the above-listed lots are supplied in 20-count cartons only. This recall is not expected to cause a drug shortage.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Drug recall: Acyclovir Sodium Injection recalled due to this reason

Drug recall: Zydus, Lupin recall products due to this issue

Drug recall: Glenmark, Strides Pharma, Cipla recalled these drugs

Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs

Drug recall: Atorvastatin 40 mg tablets recalled due to this reason

Drug recall: Magnesium Citrate Oral Solution recalled due to this reason

CDSCO Panel gives conditional nod for Nimesulide Granules

USFDA issues form 483 with 17 observations to Lupin

Govt notifies rules to exempt certain medical devices under Class A

PCI to implement Pharmacy Practice Regulations, 2015

Drug alert: 59 out of 1456 samples declared as NSQ in September 2022

Govt notifies rules to ease New Drugs and Clinical Trials norms

Govt brings these eight substances under NDPS Act

CDSCO Panel gives nod to study Anti Allergic Combination Drug

DCGI notifies classification of 48 Medical Devices related to Oncology under MDR 2017

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news